Alpha Cognition Inc Cash Flow Conversion Efficiency
Alpha Cognition Inc cash flow conversion efficiency. Based on the latest financial reports, Alpha Cognition Inc (ACOG) has a cash flow conversion efficiency ratio of -0.158x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-5.35 Million) by net assets ($33.91 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Alpha Cognition Inc (2020–2024)
Cash flow conversion efficiency of Alpha Cognition Inc from 2020 to 2024. This chart illustrates how Alpha Cognition Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View ACOG live share price for real-time trading data and today's change.
Alpha Cognition Inc Cash Flow Conversion Ratio Explained
Alpha Cognition Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Alpha Cognition Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Alpha Cognition Inc ranked by their cash flow conversion efficiency. Also see market cap of Alpha Cognition Inc for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Valiant Organics Limited
NSE:VALIANTORG
|
0.121x |
|
De Licacy Industrial Co Ltd
TW:1464
|
0.054x |
|
Sound Point Meridian Capital, Inc.
NYSE:SPMC
|
0.253x |
|
LG Corp Preferred
KO:003555
|
0.009x |
|
Eagle Cold Storage Enterprise Co Ltd
TWO:8905
|
0.038x |
|
Energy World Corporation Ltd
AU:EWC
|
-0.017x |
|
Global Dividend Growth Split Corp Class A
TO:GDV
|
0.008x |
|
Dekpol SA
WAR:DEK
|
-0.084x |
Annual Cash Flow Conversion Efficiency for Alpha Cognition Inc (2020–2024)
The table below shows the annual cash flow conversion efficiency of Alpha Cognition Inc from 2020 to 2024. Review ACOG financial flexibility index to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $41.46 Million | $-7.76 Million | -0.187x | -110.10% |
| 2023-12-31 | $-4.71 Million | $-8.73 Million | 1.852x | -73.54% |
| 2022-12-31 | $-1.32 Million | $-9.24 Million | 7.000x | +739.82% |
| 2021-12-31 | $9.03 Million | $-9.88 Million | -1.094x | +99.68% |
| 2020-12-31 | $16.01K | $-5.44 Million | -339.684x | -- |
About Alpha Cognition Inc
Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatm… Read more